Shoulder Innovations (NYSE:SI) Director Purchases $14,840.00 in Stock

Shoulder Innovations, Inc. (NYSE:SI) Director Richard Buchholz purchased 1,000 shares of the firm’s stock in a transaction on Friday, March 13th. The stock was acquired at an average price of $14.84 per share, with a total value of $14,840.00. Following the completion of the purchase, the director owned 13,666 shares of the company’s stock, valued at $202,803.44. The trade was a 7.90% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Shoulder Innovations Stock Down 0.5%

Shares of SI stock traded down $0.08 during trading hours on Tuesday, reaching $15.20. 143,803 shares of the company’s stock were exchanged, compared to its average volume of 63,386. Shoulder Innovations, Inc. has a 1 year low of $10.92 and a 1 year high of $17.94. The company has a current ratio of 11.07, a quick ratio of 9.55 and a debt-to-equity ratio of 0.11. The stock has a market cap of $313.85 million and a PE ratio of -0.07. The stock’s fifty day moving average price is $13.75 and its two-hundred day moving average price is $13.85.

Shoulder Innovations (NYSE:SI) last released its earnings results on Tuesday, March 10th. The company reported ($0.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.42) by $0.04. The firm had revenue of $14.42 million for the quarter, compared to the consensus estimate of $12.69 million. Shoulder Innovations had a negative return on equity of 37.68% and a negative net margin of 85.29%. Research analysts predict that Shoulder Innovations, Inc. will post -0.56 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. BTIG Research raised their target price on shares of Shoulder Innovations from $23.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday, March 11th. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Shoulder Innovations in a research report on Friday, January 9th. Morgan Stanley lifted their price objective on Shoulder Innovations from $18.00 to $23.00 and gave the company an “overweight” rating in a research note on Tuesday, December 2nd. Finally, Weiss Ratings restated a “sell (e)” rating on shares of Shoulder Innovations in a research note on Monday, December 29th. Five analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Shoulder Innovations presently has a consensus rating of “Moderate Buy” and an average price target of $20.80.

Institutional Trading of Shoulder Innovations

Hedge funds have recently added to or reduced their stakes in the company. Federated Hermes Inc. acquired a new position in shares of Shoulder Innovations in the third quarter worth about $2,510,000. TimesSquare Capital Management LLC acquired a new stake in shares of Shoulder Innovations during the 3rd quarter valued at about $4,799,000. Readystate Asset Management LP purchased a new position in shares of Shoulder Innovations in the 3rd quarter valued at about $511,000. Monashee Investment Management LLC acquired a new position in Shoulder Innovations in the 3rd quarter worth about $502,000. Finally, Board of Trustees of The Leland Stanford Junior University acquired a new position in Shoulder Innovations in the 3rd quarter worth about $170,000.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.